- Home
- ARCT
as 03-31-2025 2:21pm EST
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 444.5M | IPO Year: | N/A |
| Target Price: | $57.80 | AVG Volume (30 days): | 396.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.39 - $45.00 | Next Earning Date: | 03-06-2025 |
| Revenue: | $152,310,000 | Revenue Growth: | -8.69% |
| Revenue Growth (this year): | 17.02% | Revenue Growth (next year): | 83.01% |
Latest Arcturus Therapeutics Holdings Inc. News
ARCT Breaking Stock News: Dive into ARCT Ticker-Specific Updates for Smart Investing
Insider Monkey
11 days ago
Is Arcturus Therapeutics (ARCT) a Worst High-Risk High-Reward Growth Stock to Buy?
Simply Wall St.
22 days ago
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Thomson Reuters StreetEvents
24 days ago
Q4 2024 Arcturus Therapeutics Holdings Inc Earnings Call
GuruFocus.com
24 days ago
Arcturus Therapeutics Holdings Inc (ARCT) Q4 2024 Earnings Call Highlights: Navigating ...
Zacks
25 days ago
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
Associated Press Finance
25 days ago
Arcturus Therapeutics: Q4 Earnings Snapshot
Business Wire
25 days ago
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2024 Financial Update and Pipeline Progress
Business Wire
a month ago
Arcturus Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
Compare ARCT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ARCT Arcturus Therapeutics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.